SPOTLIGHT: Pfizer snaps up Coley Pharma

by admin |


Pfizer plans to buy Coley Pharmaceuticals in a $164 million tender offer, hoping to reap new products from Coley's pipeline of vaccine and immunotherapy candidates. Report

Suggested Articles

shkreli
Pharma

Supreme Court refuses to take up Shkreli's conviction appeal

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

by Kyle Blankenship
OxyContin
Pharma

How Purdue planted the opioid 'anti-story'

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

by David Armstrong, ProPublica
Entresto
Pharma

Novartis' Entresto unfazed after Merck, Bayer drug's trial win

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…

by Kyle Blankenship